203 related articles for article (PubMed ID: 22155142)
1. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
Hsu YF; Sheu JR; Lin CH; Yang DS; Hsiao G; Ou G; Chiu PT; Huang YH; Kuo WH; Hsu MJ
Biochim Biophys Acta; 2012 Feb; 1820(2):104-15. PubMed ID: 22155142
[TBL] [Abstract][Full Text] [Related]
2. p53 in trichostatin A induced C6 glioma cell death.
Hsu YF; Sheu JR; Hsiao G; Lin CH; Chang TH; Chiu PT; Wang CY; Hsu MJ
Biochim Biophys Acta; 2011 May; 1810(5):504-13. PubMed ID: 21376104
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade.
Chang HL; Chen CY; Hsu YF; Kuo WS; Ou G; Chiu PT; Huang YH; Hsu MJ
Biochim Biophys Acta; 2013 Aug; 1830(8):4053-64. PubMed ID: 23583370
[TBL] [Abstract][Full Text] [Related]
4. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29.
Law AY; Yeung BH; Ching LY; Wong CK
J Cell Biochem; 2011 Aug; 112(8):2089-96. PubMed ID: 21465530
[TBL] [Abstract][Full Text] [Related]
5. Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1‑survivin downregulation at the late phase of treatment.
Wang SC; Wang ST; Liu HT; Wang XY; Wu SC; Chen LC; Liu YW
Oncol Rep; 2017 Sep; 38(3):1587-1596. PubMed ID: 28713892
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade.
Yen CS; Chen JC; Chang YF; Hsu YF; Chiu PT; Shiue C; Chuang YF; Ou G; Hsu MJ
Sci Rep; 2016 Apr; 6():25082. PubMed ID: 27122225
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade.
Huang SW; Chyuan IT; Shiue C; Yu MC; Hsu YF; Hsu MJ
J Cell Mol Med; 2020 Jan; 24(2):1822-1836. PubMed ID: 31821701
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
Liu HF; Hu HC; Chao JI
Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
[TBL] [Abstract][Full Text] [Related]
9. The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.
Huang YH; Huang SW; Hsu YF; Ou G; Huang WJ; Hsu MJ
Sci Rep; 2015 Oct; 5():15900. PubMed ID: 26510776
[TBL] [Abstract][Full Text] [Related]
10. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
Huang X; Guo B
Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
[TBL] [Abstract][Full Text] [Related]
11. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
[TBL] [Abstract][Full Text] [Related]
14. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
[TBL] [Abstract][Full Text] [Related]
15. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
17. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity.
Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Kim HS; Kim DH; Bae SC; Hyun JW
Int J Oncol; 2013 Dec; 43(6):1907-14. PubMed ID: 24100442
[TBL] [Abstract][Full Text] [Related]
18. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
